Can clinical and urodynamic parameters predict the occurrence of neutralizing antibodies in therapy failure of intradetrusor onabotulinumtoxin A injections in patients with spinal cord injury?
Abstract Background The aim of the study was to clarify whether clinical and/or urodynamic parameters could be used to infer the probability of neutralizing antibody (NAb) formation as a possible cause of therapy failure (non-response, NR) in patients with neurogenic detrusor overactivity (NDO) due...
Main Authors: | Christian Tiburtius, Ralf Böthig, Birgitt Kowald, Sven Hirschfeld, Roland Thietje |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12894-020-00683-6 |
Similar Items
-
The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01) -
Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity
by: Sheng-Fu Chen, et al.
Published: (2015-07-01) -
Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
by: Hann-Chorng Kuo
Published: (2020-06-01) -
The Effects of Intradetrusor BoNT-A Injections on Vesicoureteral Reflux in Children With Myelodysplasia
by: Tuncay Toprak, et al.
Published: (2019-12-01) -
Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)